SCHEMBL5520032

SCHEMBL5520032

CCCCc1c(CCC)cc(C(=O)N[C@@H](C(=O)OC)c2ccccc2)c(=O)n1CCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.44
CNR1 P21554 5/20 0.44
TACR3 P29371 10/20 0.42
TACR2 P21452 3/20 0.41
TSHR P16473 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
NFKB1 P19838 1/20 0.41
MTOR P42345 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
BCL2L1 Q07817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5515333 0.93 CNR2 (0.47) CNR2CNR1TACR3TACR2TSHR
SCHEMBL5522309 0.91 CNR2 (0.48) CNR2CNR1MEN1KMT2A
SCHEMBL27680158 0.85 CNR2 (0.63) CNR2CNR1TACR3TACR2TSHR
SCHEMBL5516235 0.84 CNR2 (0.52) CNR2CNR1KMT2A
SCHEMBL2746600 0.82 CNR2 (0.48) CNR2CNR1TACR3KDM4EMEN1
SCHEMBL5517650 0.82 CNR2 (0.48) CNR2CNR1TACR3KDM4EMEN1
SCHEMBL5519688 0.82 CNR2 (0.61) CNR2CNR1TACR3TACR2TSHR
SCHEMBL27660174 0.82 CNR2 (0.61) CNR2CNR1TACR3TACR2TSHR
SCHEMBL5519973 0.79 CNR2 (0.50) CNR2CNR1TACR3KDM4EALDH1A1
SCHEMBL2745553 0.79 CNR2 (0.50) CNR2CNR1TACR3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed